Db Fitzpatrick & Co, Inc Moderna, Inc. Transaction History
Db Fitzpatrick & Co, Inc
- $103 Million
- Q1 2025
A detailed history of Db Fitzpatrick & Co, Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Db Fitzpatrick & Co, Inc holds 50 shares of MRNA stock, worth $1,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$1,361% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding MRNA
# of Institutions
925Shares Held
253MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.1 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.06 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$696 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$478 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$199 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...